S. Eva Singletary

23.8k citations

192 papers · 17.5k indexed · 5 hit papers · h-index 69

Impact in

Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Pathology and Forensic Medicine top 0.05%
- Breast Lesions and Carcinomas

Papers in

Cancer Research 150
- Breast Cancer Treatment Studies 141
- Cancer Genomics and Diagnostics 13
Pathology and Forensic Medicine 94
- Breast Lesions and Carcinomas 91

Co-authors: Henry M. Kuerer Kelly K. Hunt Gabriel N. Hortobágyi Aman U. Buzdar Merrick I. Ross Frederick C. Ames Thomas A. Buchholz Richard L. Theriault
Journals: Annals of Surgical Oncology (34 papers)Cancer (33 papers)Journal of Clinical Oncology (21 papers)The American Journal of Surgery (11 papers)International Journal of Radiation Oncology*Biology*Physics (8 papers)
Partner nations: United States United Kingdom Switzerland

In The Last Decade

S. Eva Singletary

190 papers receiving 16.9k citations

Hit Papers

5 papers align trajectories log scale

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy 2007 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Journal of Clinical Oncology
2005 Journal of Clinical Oncology
2002 Journal of Clinical Oncology
2000 Journal of Clinical Oncology
1999 Journal of Clinical Oncology

Peers

Countries citing papers authored by S. Eva Singletary

Since Specialization

Citations

This map shows the geographic impact of S. Eva Singletary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Eva Singletary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Eva Singletary more than expected).

Fields of papers citing papers by S. Eva Singletary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Eva Singletary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Eva Singletary. The network helps show where S. Eva Singletary may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Eva Singletary, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Eva Singletary Line = papers co-authored together S. Eva Singletary links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The effect of under-treatment of breast cancer in women 80 years of age and older Critical Reviews in Oncology/Hematology ·Barbara L. van Leeuwen, Kari M. Rosenkranz, Liang Feng, Isabelle Bedrosian, K Hartmann, Kelly K. Hunt, H.M. Kuerer, Merrick I. Ross, S. Eva Singletary, Gildy V. Babiera	2010	65
2	Changes in Female Support Network Systems and Adaptation After Breast Cancer Diagnosis: Differences Between Older and Younger Patients The Gerontologist ·Sato Ashida, Aunchalee E. L. Palmquist, K. Basen-Engquist, S. Eva Singletary, Laura M. Koehly	2009	24
3	Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen Clinical Cancer Research ·Aman U. Buzdar, Vicente Valero, Nuhad K. Ibrahim, Deborah Francis, Kristine Broglio, Richard L. Theriault, Lajos Pusztai, Marjorie C. Green, S. Eva Singletary, Kelly K. Hunt, Ayşegül A. Şahin, Francisco J. Esteva, W. Fraser Symmans, Michael S. Ewer, Thomas A. Buchholz, Gabriel N. Hortobágyi	2007	346
4	Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary Tumor Annals of Surgical Oncology ·Gildy V. Babiera, Roshni Rao, Lei Feng, Funda Meric‐Bernstam, Henry M. Kuerer, S. Eva Singletary, Kelly K. Hunt, Merrick I. Ross, Karin Gwyn, Barry W. Feig, Frederick C. Ames, Gabriel N. Hortobágyi	2006	187
5	Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual CA A Cancer Journal for Clinicians ·S. Eva Singletary, James L. Connolly	2006	280
6	Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy Cancer ·Linda J. Adepoju, W. Fraser Symmans, Gildy V. Babiera, S. Eva Singletary, Banu Arun, Nour Sneige, Lajos Pusztai, Thomas A. Buchholz, Ayşegül A. Şahin, Kelly K. Hunt, Funda Meric‐Bernstam, Merrick I. Ross, Frederick C. Ames, Henry M. Kuerer	2005	18
7	Paget’s Disease of the Breast: There Is a Role for Breast-Conserving Therapy Annals of Surgical Oncology ·Kazumi Kawase, Dominick J. DiMaio, Susan L. Tucker, Thomas A. Buchholz, Merrick I. Ross, Barry W. Feig, Henry M. Kuerer, Funda Meric‐Bernstam, Gildy V. Babiera, Frederick C. Ames, S. Eva Singletary, Kelly K. Hunt	2005	56
8	Small (≤2-cm) Breast Cancer Treated with US-guided Radiofrequency Ablation: Feasibility Study Radiology ·Bruno D. Fornage, Nour Sneige, Merrick I. Ross, Attiqa N. Mirza, Henry M. Kuerer, Beth S. Edeiken, Frederick C. Ames, Lisa A. Newman, Gildy V. Babiera, S. Eva Singletary	2004	157
9	Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ Cancer ·Tina Yen, Kelly K. Hunt, Nadeem Q. Mirza, Eva Thomas, S. Eva Singletary, Gildy V. Babiera, Funda Meric‐Bernstam, Thomas A. Buchholz, Barry W. Feig, Merrick I. Ross, Frederick C. Ames, Richard L. Theriault, Henry M. Kuerer	2004	40
10	Implications of Axillary Sentinel Lymph Node Biopsy in Immediate Autologous Breast Reconstruction Plastic & Reconstructive Surgery ·Steven J. Kronowitz, David W. Chang, Geoffrey L. Robb, Kelly K. Hunt, Fred C. Ames, Merrick I. Ross, S. Eva Singletary, W. Fraser Symmans, Stephen S. Kroll, Henry M. Kuerer	2002	34
11	Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. PubMed ·S. Eva Singletary, E. Neely Atkinson, Ashraful Hoque, Nour Sneige, Ayse A Sahin, Herbert A. Fritsche, Reuben Lotan, Tao Lü, Walter N. Hittelman, Therese B. Bevers, Carol B. Stelling, Scott M. Lippman	2002	36
12	The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy International Journal of Radiation OncologyBiologyPhysics ·Angela Katz, Eric A. Strom, Thomas A. Buchholz, Richard L. Theriault, S. Eva Singletary, Marsha D. McNeese	2001	144
13	Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer Annals of Surgical Oncology ·Georges Vlastos, Isabel T. Rubio, Nadeem Q. Mirza, Lisa A. Newman, Ravi Aurora, Julie R. Alderfer, Aman U. Buzdar, S. Eva Singletary	2000	70
14	Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer Annals of Surgical Oncology ·Lisa A. Newman, William C. Wood, Rena V. Sellin, Monica Morrow, Charles L. Vogel, S. Eva Singletary	2000	2
15	Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma JNCI Journal of the National Cancer Institute ·Gabriel N. Hortobagyi, Aman U. Buzdar, Richard L. Theriault, Vicente Valero, Debra Frye, Daniel J. Booser, Frankie A. Holmes, S. Giralt, Issa F. Khouri, B Andersson, James Gajewski, Gabriela Rondón, Terry L. Smith, S. Eva Singletary, Frederick C. Ames, Nour Sneige, E. A. Strom, Marsha D. McNeese, Albert Deisseroth, Richard Champlin	2000	126
16	Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues Journal of the American College of Surgeons ·Henry M. Kuerer, Kelly K. Hunt, Lisa A. Newman, Merrick I. Ross, Frederick C. Ames, S. Eva Singletary	2000	50
17	Local Recurrence and Survival Among Black Women With Early-Stage Breast Cancer Treated With Breast-Conservation Therapy or Mastectomy Annals of Surgical Oncology ·Lisa A. Newman, Henry M. Kuerer, Kelly K. Hunt, Gurpreet Singh, Frederick C. Ames, Barry W. Feig, Merrick I. Ross, Sarah Taylor, S. Eva Singletary	1999	27
18	Primary Tumor Response to Induction Chemotherapy as a Predictor of Histological Status of Axillary Nodes in Operable Breast Cancer Patients Annals of Surgical Oncology ·Jeffrey T. Lenert, Georges Vlastos, Nadem Q. Mirza, David J. Winchester, Susanne M. Binkley, Fred C. Ames, Merrick I. Ross, Barry W. Feig, Kelly K. Hunt, E. A. Strom, Aman U. Buzdar, Gabriel N. Hortobagyi, S. Eva Singletary	1999	26
19	Patient satisfaction with 23-hour "short-stay" observation following breast cancer surgery. PubMed ·Catherine C. Burke, C L Zabka, K J McCarver, S. Eva Singletary	1997	29
20	Intraarterial infusion chemotherapy in regionally advanced malignant melanoma Journal of Surgical Oncology ·Annamaria Calabro, S. Eva Singletary, Cesar H. Carrasco, Sewa S. Legha	1990	10

About S. Eva Singletary

S. Eva Singletary is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Surgery and Dermatology, having authored 192 papers that have together received 17.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (141 papers), Breast Lesions and Carcinomas (91 papers), Breast Implant and Reconstruction (56 papers), Cancer Treatment and Pharmacology (19 papers), HER2/EGFR in Cancer Research (18 papers), BRCA gene mutations in cancer (18 papers), Cancer Genomics and Diagnostics (13 papers) and Global Cancer Incidence and Screening (13 papers). The work is most often cited by research in Cancer Research (11.4k citations), Pathology and Forensic Medicine (6.7k citations), Oncology (7.9k citations), Radiology, Nuclear Medicine and Imaging (2.2k citations) and Surgery (4.2k citations). S. Eva Singletary has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Henry M. Kuerer, Kelly K. Hunt, Gabriel N. Hortobágyi, Aman U. Buzdar, Merrick I. Ross, Frederick C. Ames, Thomas A. Buchholz, Richard L. Theriault, Barry W. Feig and Marsha D. McNeese. Their work appears in journals such as Annals of Surgical Oncology, Cancer, Journal of Clinical Oncology, The American Journal of Surgery and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact